Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer

<table>Binding affinity assay of MG7-scFv/SEB to MG7 positive or negative expression cells by cell-ELISA under different concentrations, same starting concentration 1.0 <svg height="9.6750002" id="M21" style="vertical-align:-2.29482pt" version="1.1" viewbox="0 0 9.6374998 9.6750002" width="9.6374998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,9.675)">
<g transform="translate(72,-64.26)">
<text transform="matrix(1,0,0,-1,-71.95,66.6)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝜇</tspan>
</text>
</g>
</g>
</svg>g, 4 × serial dilution. (a) Binding assay of MG7-scFv/SEB to MG7 positive cell (gastric cancer cell SGC-7901) and (b) binding assay of MG7-scFv/SEB to MG7 negative cell (normal human gastric mucosal cell line GES-1).</table>

BioMed Research International

fig3

Figure 3

Figure 3: Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer 